The doses are to be jettisoned after expiring earlier this week, health authorities said on Saturday. New jabs are on the way for this autumn’s vaccination efforts.
This content was published on
2 minutes
Keystone-SDA/dos
Português
pt
Suíça vai jogar fora 10 milhões de doses de vacina contra Covid
Of the 10.3 million doses, all made by the Moderna manufacturer, 2.5 million are currently in the Swiss army’s logistics base, while 7.8 million are in an external storage depot in Belgium, the government confirmed to the Keystone-SDA news agency. The story was first reported by the Swiss news magazine Beobachter.
The Federal Office for Public Health (FOPH) told Keystone-SDA that the procurement strategy was consciously based on buying more doses than the population (of 8.7 million) needed, in order to avoid becoming reliant on a vaccine that might have proved ineffective. Surplus doses also help in case of delivery problems or unmet contracts.
More
More
Too many Covid doses: Switzerland’s vaccine conundrum
This content was published on
Switzerland is sitting on around 38 million excess Covid-19 vaccine doses to be used by the end of 2022. What will it do with them?
“Since the start of the pandemic, federal authorities have been following a procurement strategy based on different vaccine technologies and several manufacturers,” the FOPH said. The fact that both mRNA technologies bought by Switzerland – from Pfizer/BioNTech and notably Moderna – turned out to be effective, meant there was a large surplus.
The FOPH added that new Moderna vaccines, adapted to the latest Covid variants, were already starting to arrive. Some 3.5 million of them will be ready when the next vaccination campaign begins on October 10, it said. Earlier this month, the FOPH recommended that people aged 65 or over, as well as 16-64-year-olds with pre-existing health conditions, get a booster shot this autumn.
Numbers of new confirmed Covid-19 cases in Switzerland, as well as hospitalisations and deaths, have stabilised at a “relatively low level” over the past months. After two years of rolling measures, all remaining public health restrictions to fight the pandemic were lifted on April 1 this year.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
US tariffs: pharma firms not planning job cuts in Switzerland
This content was published on
The additional investments in the US will not lead to a reduction in jobs in Switzerland. This is according to pharmaceutical giant Roche, which expects the number of employees to remain stable in the current year. The position of Novartis is similar.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland approves vaccine that targets two Covid variants
This content was published on
Swissmedic awards temporary approval for new Covid-19 vaccine from Moderna, adapted to give protection against two different strains.
Swiss government recommends Covid booster from mid-October
This content was published on
The Swiss authorities have recommended that people aged over 16, especially the most vulnerable, get a Covid-19 booster shot.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.